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The renal clearance and infusion clearance of inulin are similar,
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The renal clearance and infusion clearance of inulin are similar, but not
Identical. Thirty-eight simultaneous renal (R-C,) and infusion (INF-C1)
clearances of inulin were done. The equilibration period preceding the
clearance studies was of at least two hours duration. The R-C, on each
subject was based on two clearance periods during which the plasma
inulin concentration ([P1J) varied by 1.0 mgldl or less and the rate of
inulin excretion by less than 10%. There was excellent correlation
between the R-C and the INF-C1 (r 0.976), but the INF-C1
consistently exceeded the R-C1 (mean difference = 13.8 8.8 mi/minI
1.73 m2, t = 9.7163 and P = <0.001). Complete equilibration of inulin
in body fluids has been assumed when (PJ levels were relatively
constant (variation < 10%). However, complete equilibration of inulin
would not be present, even with relatively constant Pa,, levels, if the rate
of infusion of inulin were equal to the rate of excretion plus the rate of
penetration of inulin into less permeable components of the extracellu-
lar fluid compartment (that is, dense connective tissue solids). Estima-
tion of glomerular filtration rate using the INF-C, requires complete
equilibration of inulin in body fluids, a process probably requiring 12 to
15 hours or longer.
The renal clearance of inulin (R-C1) is accepted as the
reference standard for estimation of glomerular filtration rate
(GFR) [1—3]. The two major problems encountered in estimat-
ing GFR using the renal clearance of inulin are the equilibration
of the filtration marker in body fluids and collection of timed
urinary specimens. In the absence of bladder catheterization,
inaccurate collection of urine is usually considered the major
source of error in renal clearance studies. Earle and Berliner
were the first investigators to describe an infusion equilibrium
technique for estimation of inulin clearance without urine
collection [4]. This approach is based on the concept that "for
any exogeneous substance which is neither metabolized, stored
nor excreted otherwise than in the urine, the rate of excretion
must be equal to the rate of infusion under conditions where its
plasma level and volume of distribution are constant" [5].
There are studies in the literature of simultaneous measure-
ment of R-C1 and infusion clearance of inulin (INF-C1) carried
out on 73 renal patients and 68 subjects with normal kidney
function [4—10]. There was good correlation between the renal
and infusion clearances in these studies, and in most instances
the concomitant R-C1 and INF-C1 differed by only a few
Received for publication August 3, 1993
and in revised form June 10, 1993
Accepted for publication June 11, 1993
© 1993 by the International Society of Nephrology
mI/min/! .73 m2. The largest study reported, that of Cole et al,
consisted of 61 pediatric patients in whom the R-C1 was
calculated using urine collection periods of approximately one
hour between the third and fourth, and fourth and fifth, hours of
infusion [7]. Urine collections were by spontaneous voiding or
catheterization. The correlation coefficient of the linear regres-
sion between the R-C1 and the INF-C, was 0.993, with the
INF-C, averaging 3% higher than the R-C1.
The seemingly sound theoretical basis underlying the infusion
clearance concept and the published data indicating the near
equivalence of renal and infusion clearances of inulin led us to
initiate concomitant R-C1 and INF-C1 studies in patients in
whom accurate estimates of GFR were needed. The data we
accumulated over several years showed that the INF-C1 was
almost always 15% to 20% larger than the R-C1. Since studies
by a number of competent investigators had yielded different
results, we initially assumed we had made technical or proce-
dural errors [4-10]. However, careful review of our procedures
and the introduction of a second method of inulin assay have
not revealed a methodological problem as an explanation for the
disparity, so we are reporting the data obtained in these studies.
Methods
Patients
Thirty-eight simultaneous R-C1 and INF-C1 studies were
conducted on subjects participating in several research proto-
cols in which the R-C1 was required. The research protocols
had been approved by the University of Missouri-Kansas City
(UMKC) Institutional Review Board for the adults and by the
UMKC Health Sciences Pediatric Institutional Review Board
for the pediatric patients. Informed consent was obtained prior
to conducting these studies. There were five adult volunteers,
three male and two female, and 33 pediatric patients, Sixteen of
the pediatric patients were male. The age of the pediatric
patients was from 8.1 to 21 years (14.6 3.3 years). All urine
specimens were obtained by spontaneous voiding, with the
subjects using a double-voiding technique. Plasma, urine, and
infusate inulin concentrations were determined using the an-
throne method in the first 23 studies and with an automated
enzyme assay in the 15 most recent studies.
The priming solution of inulin, designed to bring the concen-
tration in extraceliular fluids to 25 mg/dI, was infused over 10
minutes. The sustaining solution was infused at 0.5 mI/mm
using a calibrated infusion pump. The concentration of inulin in
the sustaining solution was set so the rate of infusion of inulin
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approximated the rate of excretion, based on the most recent
measured or calculated creatinine clearance [11]. The equilibra-
tion periods were of at least two hours duration. Depending on
the particular research protocol, the inulin infusion was contin-
ued from two to six and one-half hours after equilibration, and
there were four to six renal clearance periods.
Inulin assay
Anthrone. The first 23 paired renal and infusion clearance
studies were derived from inulin assays using the anthrone
method [12]. All samples were run in triplicate. Control plasma
and urine inulin samples and plasma and urine blanks were run
with each assay. The coefficients of variation (CV) for estima-
tion of plasma and urine inulin concentrations were derived
from the data of 39 inulin clearance studies carried out over a
two year period. The 25.0 mg/dl plasma inulin control sample
had a mean value of 25.1 0.4 mgldl and a CV of 1.6%. The 200
mgldl and 400 mg/dl urine inulin control samples had mean
values of 200 4 mgldl and 400 5 mgldl and CVs of 2.0% and
1.6%, respectively.
Enzymatic. The 15 most recent paired clearance studies were
carried out with inulin concentrations measured using an auto-
mated enzymatic system with hydrolysis of inulin with inuli-
nase. The enzymatic analyses were automated on a Gilford
400E Automated Chemistry Analyzer. A 40 mgldl calibrating
solution was used to set the analyzer for the plasma samples
and a 150 mgldl calibrator for the urine and infusate specimens.
All samples were run in triplicate. Control plasma and urine
samples and plasma and urine blanks were run with each assay.
Reproducibility data, based on 24 sets of control plasma and
urine specimens from studies conducted over a six month
period, yielded the following: 25 mgldl plasma 25.7 0.5
mgldl (CV = 1.9%) and 100 mgldl urine = 105.7 3.6 mg/dl (CV
= 3.4%). Eight control urine samples run over the last two
months of the six month period yielded the following: 150 mg/dl
urine = 153.4 2.5 mgldl (CV = 1.4%).
The anthrone and enzymatic methods were compared in 30
R-C1 studies with plasma, urine, and infusate inulin concentra-
tions measured using both the anthrone and enzymatic assays
[13]. The correlation coefficient of the regression of the R-C1
derived using the two methods was 0.977. The mean difference
showed that the anthrone method yielded clearances that were
2.6 4.8 mllminIl .73 m greater than the enzymatic procedure.
The concentration of inulin in the sustaining solution used in
calculation of the INF-C1 was the average of the concentration
of inulin measured in samples obtained prior to and following
the clearance study. The inulin solutions were prepared by the
hospital pharmacy where an aliquot of the sustaining solution
was removed for analysis. At the end of the infusion study a
second aliquot of the sustaining solution from the soluset and
tubing was removed for inulin assay along with the pre-infusion
sample.
Calculations
The R-C1 on each subject was based on two clearance
periods during which the Pt,, concentrations varied by 1.0 mgldl
or less and the rate of inulin excretion (mg!minll .73 m) varied
by less than 10%. The average R-C1 was compared with the
INF-C. The former was calculated in the usual way and the
latter from the average of the [P] levels during the R-C1
Mean ra
Paired i-test
Mean duff t P
All data (N = 38)
R-C1
mi/mini 80.8 38.6
1.73 m2
INF-C0 0.976 13.8 8.8 9.7163 <0.001
mi/mini 94.6 40.3
1.73 m2
Anthrone assay
data (N = 23)
R-C1.,
ml/mini 69.2 36.1
1.73 m2
INF-C1 0.978 14.4 7.8 8.8133 <0.001
mi/mini 83.6 37.6
1.73 m2
Enzymatic assay
data (N = 15)
R-C
mi/mini 98.4 36.5
1.73 m2
INF-C1 0.967 12.9 10.3 4.8842 <0.001
mi/mini 111.4 39.7
1.73 m2
periods, the inulin infusion rate (R) and the concentration of
inulin in the sustaining solution (I). In calculation of the infusion
clearance IR is substituted for U1V in the standard clearance
formula.
UinV
= IN
[P1]
IR
F-C1 = [P]
Results
The concentrations of inulin in the sustaining solution, mea-
sured prior to and following the infusion, were not significantly
different. Using the paired t-test, the mean difference was 0.25
1.77 mg/mI, the t value 0.8638, and the two-sided significance
level 0.3932. The average of the measured pre- and post-
infusion concentration of inulin in the sustaining solution, that
used for calculation of the INF-C1, was compared with the
inulin infusion concentration calculated from the orders given
to the Pharmacy. Using the paired t-test, the mean difference
was 0.44 mglml, the t value 1.6206, and the two-sided signifi-
cance level 0.1136. The infusion was delivered at a rate of 0.5
mllmin using a calibrated infusion pump. The infusion rate was
monitored in 27 of the 38 studies by dividing the total volume of
sustaining solution infused as measured in the soluset by the
time of infusion. The infusion rate by this monitor was 0.498
0.006 mllmin.
The data from the 38 studies in which the R-C1 was com-
pared with the INF-C1 are shown in Table 1. There is excellent
correlation between the R-C1 and INF-C1 (r 0.976). Figure
I presents the data graphically with the studies derived using
the anthrone method indicated by crosses and those based on
Table 1. Comparison of the renal and infusion clearances of inulin
using two methods for inulin assay
a Correlation coefficient for linear regression of R-C, vs. INF-C1.
All of the clearance data were corrected to 1.73 m2 SA.
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the enzymatic assay denoted by solid dots. The observation
that the INF-C1 is greater than the R-C1 is evident in data
derived using either the anthrone or the enzymatic method for
inulin assay (Table 1). In the 23 studies conducted using the
anthrone method the INF-C1 overestimated the R-C1 by 14.4
7.8 mllmin/1.73 m2. In the 15 studies in which inulin was
measured using the enzymatic method the INF-C1 overesti-
mated the R-C1 by 12.9 10.3 mlIminIl.73 m2. Combining the
data from the 38 paired studies, the INF-C1 exceeded the R-C1
by 13.8 8.8 ml/min/1.73 m2. As shown in Table 1, these
differences were statistically significant (paired i-test). Multiple
linear regression analysis was done with the INF-C1 as the
dependent variable and the R-C1 and the methods of inulin
assay as independent variables. The regression showed that the
R-C1 accounted for essentially all the variation in the INF-C1
(t = 27.1162, P = <0.001) and that the method of inulin assay
did not make a significant contribution (t = 0.7447, P = 0.461).
Discussion
The data obtained in this study show a close correlation
between the R-C1 and the INF-C1 (r = 0.976), with the
INF-C1 exceeding the R-C1 by 13.8 8.8 mllmin/1.73 m2
(17.0%). Earlier investigators also found good correlation be-
tween the R-C1 and the INF-C1, but with the INF-C1 equal to
or only slightly larger than the R-C1 [4—10]. The difference
between the INF-C1 and R-C1 in the data of the current study
is present because the inulin infusion rate, IR, exceeds the renal
excretion rate, UV. The other value in the clearance equation,
[P1], is essentially the same for calculation of both the R-C1
and INF-C1. There are several possibilities which might ex-
plain the low renal inulin excretion rate compared with the
inulin infusion rate. The first to be considered is that the urinary
collections, obtained by spontaneous voiding, were consis-
tently low in the 38 paired renal clearance studies. This seems
unlikely since urine flow rates were at diuretic levels throughout
and, in the majority of instances, the two renal clearance
periods were sequential. It is not unusual to detect a fall in
urinary volume due to incomplete bladder emptying during
sequential renal clearance studies in children. When this occurs
the problem is usually obvious, and the volume of the urinary
specimen and the inulin excretion rate during the next clearance
period is unusually large. The rate of excretion of inulin would
be low were the measured concentration of inulin in urine less
than the actual concentration. This also seems unlikely, since
urinary inulin control samples run with each study showed
essentially 100% recoveries in the spiked samples and the
findings were the same using the two methods of inulin assay.
The inulin infusion rate would exceed the excretion rate were
the concentration of inulin in the sustaining infusion (I) consis-
tently overestimated or were the infusion pump rate consis-
tently lower than the 0.5 mllmin. This is unlikely since the
measured concentration of inulin in the sustaining solution was
close to that ordered from the pharmacy, and the monitored
rate of infusion of the sustaining solution by the calibrated
infusion pump was consistently close to 0.5 mI/mm.
The INF-C1 would not be identical with the R-C1 were inulin
not equilibrated in body fluids (in spite of the presence of a
stable [P1]). There is no evidence that inulin is metabolized,
stored or excreted otherwise than in the urine [1—3], but there
are data indicating that the volume of distribution of inulin may
not be reached after the usual equilibration period of one to
three hours [4—10, 14]. The failure of inulin to be equilibrated in
body fluids would not be reflected by a changing plasma inulin
concentration were the rate of infusion equal to the rate of
excretion plus the rate of penetration into the less permeable
components of the interstitial matrix of the extracellular fluid
compartment [8].
In a study of the distribution of inulin (and sucrose) in the
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Fig. 1. Comparison of the R-C,,, and INF-C,,,
using the anthrone (+) and enzyme assay (•)
methods for inulin determination. The dotted
lines denote the 95% confidence interval. y =
1.02x + 12.07; r = 0.976.
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chloride space of rats, Cotlove found that the extent of distri-
bution in muscle and subcutaneous tissue was time-dependent
in a biphasic manner [141. In the initial phase of about two
hours, the distribution appeared to reach about four-fifths of the
chloride space, representing equilibration of the rapid compo-
nent. In the second phase there was a gradual increase in the
volume of distribution with the slow component approaching
equilibrium over a period in excess of six and probably of 15
hours. Based on in vitro diffusion studies in tendon, Cotlove
concluded that the slow phase of inulin distribution in vivo
reflects the gradual penetration of dense connective tissue such
as tendon and the facial sheaths and septa of muscle. Rat
muscle contains about 10 grams of connective tissue solids per
kilogram associated with extracellular fluid, amounting to about
one-fifth of the chloride space. This volume of extracellular
fluid is similar in magnitude to the slow phase of inulin distri-
bution.
There are some data which suggest that inulin distribution in
humans is similar to that found in rats. Mokotoff, Ross and
Leiter analyzed muscle biopsies in four human subjects without
edema after six hours of constant inulin infusion [15]. The inulin
volume of distribution averaged 0.82 of the chloride space in
muscle. Schwartz, Schachter and Frienkel, using the constant
infusion technique, found an apparently stable volume of dis-
tribution of inulin in humans after five hours [16] but, according
to Cotlove, this probably represents the more rapid phase of the
inulin volume of distribution [14]. Finkenstaedt, O'Meara and
Merrill administered a single dose of inulin to 14 anuric patients
who were fluid restricted so that they lost weight during the
period of study [17]. In 12 patients the "inulin space" averaged
24% (20.8 to 31%) of body weight at eight hours and in 10 of the
patients it averaged 30.2% (23.5 to 37%) at 24 hours. The slow
phase of inulin distribution is quantitatively important since
over half of total body extracellular fluid is contained in tissues
with slow distribution in significant fractions of their extracel-
lular volumes [for example, skeletal muscle, loose connective
tissue (subcutaneous tissue) and dense connective tissue (ten-
don)] [141.
The biphasic distribution of inulin in the extracellular volume
appears to explain the data of the present study showing that
the inulin infusion rate exceeded the inulin excretion rate even
though [P] levels were constant. Although this may explain
our observation showing that the INF-C1 is about 17% larger
than the R-C1, it does not explain why other investigators
found little difference between the two clearances. During the
last 20 years, the period since publication of the study by Cole
et al showing that the value for the INF-C1 was on the average
3% larger than the R-C1 [7], it has been rare to encounter
investigations in which the INF-C1 has been employed for
measurement of GFR. In commenting on the infusion clearance
technique, Homer Smith stated, "The technique is sound in
principle, but the investigator should satisfy himself of his
competence to check bladder clearances by this method. Work-
ers in the writer's laboratory have been rather disappointed in
this respect and have not substituted the infusion technique for
bladder clearances in any important study, even in those
extending over periods of 24 hours where it would be most
useful." The data of the present investigation lead to a hypoth-
esis which we hope to test, that complete equilibration of inulin
in the extracellular volume is a process which requires an
infusion of 12 to 15 hours or possibly longer.
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